{"id":448370,"title":"Health Product InfoWatch: October 2022 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T16:45:02.463000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html?wbdisable=false","snippet":"Health Product InfoWatch: October 2022 Contents Health products mentioned in this issue Coronavirus disease (COVID-19) Drug and vaccine authorizations and communications for COVID-19 Actemra (tocilizumab) Comirnaty Original & Omicron BA.4/BA.5 Bivalent Vaccine (COVID-19 mRNA…","rawSnapshotUrl":"/api/snapshots/raw/448370","browseUrl":"https://replay.healtharchive.ca/job-6/20260103164502/https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html?wbdisable=false#ha_snapshot=448370","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}